NVIVQ — InVivo Therapeutics Holdings Cashflow Statement
0.000.00%
Last trade - 00:00- $1.06m
- -$7.53m
- 12
- 57
- 19
- 19
Annual cashflow statement for InVivo Therapeutics Holdings, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -23.4 | -11.8 | -9.07 | -9.89 | -10.5 |
| Depreciation | |||||
| Non-Cash Items | 12.2 | 1.2 | 0.498 | 0.643 | 0.544 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -1.22 | 0.259 | -1 | 0.354 | -0.596 |
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Cash from Operating Activities | -12.3 | -10.3 | -9.53 | -8.85 | -10.5 |
| Capital Expenditures | -0.065 | -0.012 | -0.041 | -0.077 | -0.16 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0 | — | — | — | — |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -0.065 | -0.012 | -0.041 | -0.077 | -0.16 |
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 15.9 | 0.268 | 22.5 | 8.51 | 7.96 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 3.5 | -10.1 | 12.9 | -0.422 | -2.68 |